Viral entry, the first process in the reproduction of viruses, primarily involves attachment of
the viral envelope proteins to membranes of the host cell. The crucial components that play an important
role in viral entry include viral surface glycoprotein gp120, viral transmembrane glycoprotein gp41, host
cell glycoprotein (CD4), and host cell chemokine receptors (CCR5 and CXCR4). Inhibition of the multiple
molecular interactions of these components can restrain viruses, such as HIV-1, from fusion with
the host cell, blocking them from reproducing. This review article specifically focuses on the recent progress
in the development of small-molecule HIV-1 entry inhibitors and incorporates important aspects of
their structural modification that lead to the discovery of new molecular scaffolds with more potency.